1. Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer
   Ahmed Faris Aldoghachi et al, 2019, Disease Markers CrossRef
2. The Antiviral Effect of High-Molecular Weight Poly-Gamma-Glutamate against Newcastle Disease Virus on Murine Macrophage Cells
   Melbourne Talactac et al, 2014, Advances in Virology CrossRef
3. Development and application of oncolytic viruses as the nemesis of tumor cells
   Xiao Zhu et al, 2023, Frontiers in Microbiology CrossRef
4. Newcastle disease virus suppresses angiogenesis in mammary adenocarcinoma models
   A. M. Al-Shammari et al, 2022, BULGARIAN JOURNAL OF VETERINARY MEDICINE CrossRef
5. TARBP2 inhibits IRF7 activation by suppressing TRAF6-mediated K63-linked ubiquitination of IRF7
   Ting Ling et al, 2019, Molecular Immunology CrossRef
6. Oncolytic Viral Therapy for Mesothelioma
   Daniel F. Pease et al, 2017, Frontiers in Oncology CrossRef
7. Autophagy, TGF-β, and SMAD-2/3 Signaling Regulates Interferon-β Response in Respiratory Syncytial Virus Infected Macrophages
   Swechha M. Pokharel et al, 2016, Frontiers in Cellular and Infection Microbiology CrossRef
8. Multimodal Cancer Therapy Involving Oncolytic Newcastle Disease Virus, Autologous Immune Cells, and Bi-Specific Antibodies
   Volker Schirrmacher et al, 2014, Frontiers in Oncology CrossRef
9. Recent advances of oncolytic virus in cancer therapy
   Moumita Mondal et al, 2020, Human Vaccines & Immunotherapeutics CrossRef
10. Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
    Volker Schirrmacher et al, 2022, International Journal of Molecular Sciences CrossRef
11. Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
    Fang Huang et al, 2022, Frontiers in Molecular Biosciences CrossRef